Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naama Rotenberg

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biomolecules|October 29, 2025
Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma ActivityMark Feldman, Naama Rotenberg, Julia M Shifman
Trends in Biochemical Sciences|September 11, 2025
Engineered protein inhibitors for precise targeting of matrix metalloproteinasesNaama Rotenberg, Noam Y Bentolila, Julia M Shifman
The Journal of Biological Chemistry|October 17, 2024
Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cellsNaama Rotenberg, Mark Feldman, Jason Shirian, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2024
Mirror-Image Random Nonstandard Peptides Integrated Discovery (MI-RaPID) Technology Yields Highly Stable and Selective Macrocyclic Peptide Inhibitors for Matrix Metallopeptidase 7Hiba Ghareeb, Choi Yi Li, Anjana Shenoy, et al.
Biomolecules|September 28, 2024
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide ExtensionJason Shirian, Alexandra Hockla, Justyna J Gleba, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide ExtensionJason Shirian, Alexandra Hockla, Justyna J Gleba, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biomolecules|October 29, 2025
Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma ActivityMark Feldman, Naama Rotenberg, Julia M Shifman
Trends in Biochemical Sciences|September 11, 2025
Engineered protein inhibitors for precise targeting of matrix metalloproteinasesNaama Rotenberg, Noam Y Bentolila, Julia M Shifman
The Journal of Biological Chemistry|October 17, 2024
Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cellsNaama Rotenberg, Mark Feldman, Jason Shirian, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2024
Mirror-Image Random Nonstandard Peptides Integrated Discovery (MI-RaPID) Technology Yields Highly Stable and Selective Macrocyclic Peptide Inhibitors for Matrix Metallopeptidase 7Hiba Ghareeb, Choi Yi Li, Anjana Shenoy, et al.
Biomolecules|September 28, 2024
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide ExtensionJason Shirian, Alexandra Hockla, Justyna J Gleba, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide ExtensionJason Shirian, Alexandra Hockla, Justyna J Gleba, et al.
Pageof 1